Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending March 17, 2023

Drug Industry TRx: -0.2% w/w; +8.3% y/y

Vascepa
TRx 59,420; -4.1% (-2,561) w/w; -18.6% y/y
NRx 27,716; -6.3% (-1,863) w/w; -17.6% y/y
Ref 31,704; -2.2% (-698) w/w; -19.4% y/y

Fake Vascepa
TRx 45,676; -1.1% (-492) w/w; As % of total V: 43.5%
NRx 22,423; -2.0% (-456) w/w; As % of total V: 44.7%
Ref 23,252; -2.2% (-36) w/w; As % of total V: 42.3%

Fake Vascepa by Manufacturer
Hikma TRx 16,463; Gen share 36.0% Total V share 15.7%
Reddy TRx 18,831; Gen share 41.2%; Total V share 17.9%
Apotex TRx 8,576; Gen share 18.8%; Total V share 8.2%
Teva TRx 897; Gen share 2.0%; Total V share 0.9%
Northstar TRx 908; Gen share 2.0%; Total V share 0.9%

Vascepa + Fake Vascepa
TRx 105,096; -2.8% (-3,054) w/w; +1.4% y/y
NRx 50,140; -4.4% (-2,319) w/w; -1.1% y/y
Ref 54,956; -1.3% (-734) w/w; +3.9% y/y

Lovaza (Fake & Brand)
TRx 64,652; -3.7% (-2,473) w/w; +2.0% y/y
NRx 32,995; -2.8% (-942) w/w; -0.3% y/y
Ref 31,657; -4.6% (-1,531) w/w; +4.5% y/y